Clinical Trial Update: Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System [NA]

View source ↗

Summary

This document outlines an early feasibility study of the Nyra Cardiac Leaflet Enhancer (CARLEN) System for mitral regurgitation. The study is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Drugs mentioned

• Nyra Cardiac Leaflet Enhancer (CARLEN) System

Snippet

Sponsor: Nyra Medical, Inc. | Conditions: Mitral Regurgitation Functional | NA | Status: NOT_YET_RECRUITING